Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Sector: Healthcare; Industry: Biotechnology

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. Iovance Biotherapeutics, Inc. has collaboration agreements with Moffitt, M.D. Anderson Cancer Center, Ohio State University, and MedImmune; and research collaboration with Cellectis S.A. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2018-12-18 Dukes Iain D. Director Buy 12,000 $8.65 $103,796 No
2018-12-13 MCPEAK MERRILL A Director Buy 10,000 $9.63 $96,273 No
2018-12-06 Rothbaum Wayne P. Director Buy 1,221,053 $10.20 $12,454,056 No
2016-08-25 Hillsberg Sanford Director Sell 54,000 $8.95 $483,412 No
2016-08-22 Hillsberg Sanford Director Sell 54,000 $9.11 $491,740 No
2015-09-08 Hillsberg Sanford Director Sell 32,500 $6.99 $227,085 No
2015-08-03 Hillsberg Sanford Director Sell 32,500 $8.15 $264,875 No
2015-05-01 Ayer Capital Management, LP 10%-Owner Sell 2,780,682 $9.62 $26,752,385 No
2015-05-06 Hillsberg Sanford Director Sell 50,000 $10.00 $500,000 No
2014-11-06 BRISTOL INVESTMENT FUND LTD 10%-Owner Sell 100,000 $690000.00 $69,000,000,000 No
2013-11-05 MCPEAK MERRILL A/ Director Buy 50,000 $2.00 $100,000 Yes
2013-11-05 Singh Manish President & CEO Buy 125,000 $2.00 $250,000 Yes
2011-08-22 Schroeder Martin Director Buy 1,000,000 $0.00 $1,000 No
2011-07-21 MCPEAK MERRILL A/ Director Buy 10,000 $1.40 $14,000 No

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.